







'jI t 't t'\J






.i;ao ,lltto* ,s.oS,i c.lc 6li Uiin[5, l5{jg c,if ?5,.*.,*I5if {f ).ra







tstA oirl ! fr*"| ;l5rJ i),.- rl ,o ;lrlro 3ly) u-l;r9l =L J:r-.--o:;^:.i.ra 9 c4!r,ir
+, a5 ,1c9., 
.,Sti ,s^Sj .lrr; J)r jl .-,1-,L* ;_l ss9, *f u;rlf ,iS rlr- _,. .:-1J;;
JNgSyS p"*15,jb o.f p-jilc -r^iL, ocls.r*L e-t" e_1-, pr*.,-l .gtos rs.r.Z ! rL..
pJ ,s- 'tl; p9--1 o.l;5 ,i/-^ ff* alrL*.s-S.f ;Lr.: rol_,r qSI-;;
rrr di )1 
..r ei*,I jl *rU .iJ-q fr*" d!rt* A. ,.sfr .Sj dJtL. ;lr.: :e;9; I clf
q:.rre r;r; 
-,l;xl dJLo; rsyo 4, (BLL): 20 pg/dl of ?)- *_ t ,5-S;
jrr q 
.r"sr- ;Lr.: ;^;' @:25).roL- ogrf .r*f )p sr.rJl ,JL" , ,.rl! *<i_)9-:,'-
\', 
.,l*ii jts ! .-,#r, o9>G aL-lu 
"9-S oS .JE r". -'-.;-arSrl; al; JUrr, ..lrng i k_U
.J"F" lr .rlrL* ,j-S-i r)r clr; rJ.:f .-cL-, 
" 
;; I \ . .sr_;l ,_f.;1.: ;L;frt F"--15 .,.r .,-*.
a""-'rLr.: jl .r, aiijj.:2. 9 Y. ,\A 9 G^S^i crc;Lrs jl J+ (r- *]*. \.. b .) (VAS)
.5tA#t. .i..-y.9lr..r: p[.>..;l \1..SPSS );l ey;l o.:lc*,| t .srLI J"I=,9 dr_F..rr
klf ,": jl o.roL:. ell. i-f ,!f osl;';.,t J.,f ;t** .slr..;l, ar;(;L .JLr g.jy ! .,*(
.gl; one-rvay ANOVA , F-test ,rj.[ ..r-: oc[-p.-.,I T .rrjI ,l "s-f ,-o ,c .jlii- .-j-:
.u; rlr-i o.:l;'-*.1 J_,9.o ,tlr e.j-, :J r- I ..-l*1--
. ;,1 a:;ls.grlc L- i)lSl 
.-rL_,r tr.$ jl J+ os-f sr;1r.:VAS 9 ?)- et- :Lo a:-it_
(Al /Y + YY.Y 9d?l? + \?l?,).",+iA*f r+l-il.r. oyF;r.,^S;.:r.:9uroe.!_*
.;JJ S\-toyf ,Jp-rr o-r;;_f'Lr+)rr9.:.(mml\ l?+ \./y JU-r.:i1.y+ \t.;.
os-Fsr.-,*t1rrl.:L--i)t lS (rF,J:^ \.4 + \V JU-r;V.V \.vt \.f) .r-S.i::
aLj-l,u os_f ;r ,?Yl\ t 1./1 J;l,S os-f 
-tr VAS \A a.iiii;rr.;Lrr jl .r"..&)*j clr*
os-f sr crrr J;r(P= '1"Y)2'r(p:0/04>r. +ii.jr,c cr51.r*,.r;oS(p:ns) ?flv +' - '
.g[a orgc fk' -,r cr.: .i^o|f ,.> .grl.: .r:- j)L;l a.t=l,r^ os_f ;J.-;1.: .grl.: ,r;--o _;rI
9?. Jli*)J \A .Y. .}iU- rr \4,?. JG^)r . .Y. JU- )r . .\A JU- r.: .) o.u . !J
)r . 9 \A JG- -,r . _rr Q;.xrrf ;l osl-c-l of Jt- )J. r; or,_r(a-o-rs P. .-f,G- r: r.
.ry. y y" , ii,j.: Y. .'L!
F"-5 ;crS a-iL-l .srls o*ii:* tlirl pJS 9 ?)-,.*!fL .:lc ,L; ta d:it_ :6-f 4-*.ij
-Jc a, l; :,r! c*-?* jl .',:,tj .s-Sj crc al.oG)L aptf &Ur- t 6!,t9 arUfi.
.Sb-,[f a$. 4:,o9;. +t- .s^ +"1;l ;.cL .i_ .Slf , JaJ .r^ ,UtS ?)- q "srJ1 St_r; .-s,,^-.
\,)-tt f9'* .-,1-,L* ,j-Si .:r,: ;L"rs 




-^J! .+t;1r5 ..:r- jl .+U ,=J-isrs . cg.l,.,,9 c,Ef ,K p=-5 :Lo ojlg .ql5
a
The Effect of adding intravenous calcium gluconate on lead-induced
abdominal pain, a randomized clinical trial study
objective: Iranian emergency physicians reported thousands of opium
users attending emergency departments throughout the country with severe
abdominal pain not responding to any opioid-mimicking substance [1]. Vfe
aimed to investigate the effect of intravenous calcium gluconate on lead-
induced abdominal pain in opium dependent patients.
Methods: In a single-center study, fifty adult age-matched lead poisoned
patients with abdominal pain and blood lead level (BLL)> 20 ytgldL were
randomly recruited, divided consecutively and underwent cardiac
monitoring and pulse oximetry. The control group (n:25) treated with
starting morphine dose of 0.1 mg / kg and normal saline and it increased if
equi-analgesic daily oral morphine use was more. While intervention group
treated additionally with 10 mL intravenous calcium gluconate l\Yo. The
Visual Analogue Scale (VAS) was determined in each patient to measure
pain severity (0 to100 mm) before abdominal pain treatment, and 15, 30
and 60 minutes after treatment. Statistical analysis was done using
SPSS.19.0. For the description of quantitative variables with normal
distribution, mean (+SD) was used. To see the effect of treatment drugs on
VAS in different time intervals, student T test was used in each group. F-
test and one-way ANOVA applied for analysis and interpretation of two
drugs regimen.
Results: BLL and VAS had no significant baseline differences before any
treatment in intervention and control groups (56.6+16.6 vs. 59.2+22.2
pgldL md 69.3+11.6 vs. 67.0+10.3 mm respectively). Morphine dose
t5
administered similarly in both group for relief of abdominal pain (7.8+1.4
vs. 7.8+1.4 n g). After treatment, vAS dropped to 67.1+10.9 vs. 64.7+10.4
mm 15 minutes later (p:ns),58.0+11.2 vs. 64.6+10.9 mm in 30 minutes
(p:0.041), and 53.6+10.9 vs. 63.8+10.7 mm in 60 minutes (p:0.002).There
was a significant difference in reducing pain in all defined time intervals (0
vs. 15, 0 vs. 30, 0 vs 60, 15 vs. 30, 15 vs. 60 and 30 vs. 60 minutes) in
intervention group. While using morphine solely was effective in 0 vs. 15,
and 0 vs. 30 minutes (p<0.01).
Conclusion: The metabolism of lead and calcium are known to be
correlated 12, 3]. Adding intravenous calcium gluconate to morphine
sulfate immediately decreases the severity of lead-induced abdominal pain
due to ingestion of lead contaminated opium and persisted for an hour.
Further interventional studies are recommended to see if response to
calcium salts in suspected lead-induced abdominal pain could be an
indicative of lead toxicity.
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